2018 Webinar Series: Treatment of Substance Use Disorders in Primary Care

This complimentary webinar series, funded through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care. CME is available for up to one year following each webinar recording date.

    Part 1:  Suboxone 2.0: Beyond the Basics; Ritu Bhatnagar, MD and John Ewing, MD, presenters

    Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.

    Recording date: June 20, 2018 | View Webinar  (CME is no longer available for this session)

    Part 2: Interpretation of Urine Drug Screen; David Galbis-Reig, MD, presenter

    Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.

    Recording date: July 18, 2018 | View Webinar  (CME is no longer available for this session)

    Part 3: Treatment of Stimulant Disorder; Mark Lim, MD, presenter

    Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder. 

    Recording Date: August 15, 2018 | View Webinar  (CME is no longer available for this session)

    Part 4: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD 

    Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.

    Recording Date: October 17, 2018 | View Webinar  (CME is no longer available for this session)

    Part 5: Treatment and Withdrawal Management of Alcohol Use Disorder, presented by Tim Cordes, MD

    Learning Objectives: Identify elements from a patient’s history and presentation that suggest the potential for more symptomatic alcohol withdrawal; Describe medications which are used for management of outpatient alcohol withdrawal; List indications for and common risks of naltrexone for alcohol use disorder.
    Recording Date: May 3, 2019 | View Webinar (CME is no longer available for this session)

    Contact WISAM

    563 Carter Court, Suite B
    Kimberly, WI 54136

    Social Media Center

    Donate Today!

    Help fund WISAM
    WISAM is funded in part by generous donations from patrons such as yourself.  Click here to make your donation today.  Your donation is tax deductible.

    Copyright © 2018 WISAM All rights reserved.  | Terms of Use | Privacy Policy

    The Wisconsin Society of Addiction Medicine (WISAM) is headquartered in Kimberly, WI.
    Contact us today for more information about our organization!

    Powered by Wild Apricot Membership Software